PMC:7073332 / 0-690
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2 | 35-52 | Species | denotes | novel coronavirus | Tax:2697049 |
3 | 53-62 | Species | denotes | 2019-nCoV | Tax:2697049 |
38 | 84-89 | Species | denotes | Human | Tax:9606 |
39 | 90-103 | Species | denotes | coronaviruses | Tax:11118 |
40 | 123-168 | Species | denotes | severe acute respiratory syndrome coronavirus | Tax:694009 |
41 | 170-178 | Species | denotes | SARS-CoV | Tax:694009 |
42 | 184-206 | Species | denotes | 2019 novel coronavirus | Tax:2697049 |
43 | 208-217 | Species | denotes | 2019-nCoV | Tax:2697049 |
44 | 233-243 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
45 | 361-370 | Species | denotes | 2019-nCoV | Tax:2697049 |
46 | 371-381 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
71 | 292-301 | Disease | denotes | mortality | MESH:D003643 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 63-71 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 123-156 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T3 | 170-178 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T4 | 233-241 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 371-379 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 84-89 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | Human |
T2 | 648-649 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 14-18 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T2 | 345-350 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T3 | 430-434 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T4 | 468-473 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T5 | 538-542 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T6 | 596-610 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
T7 | 596-605 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T8 | 606-610 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-73 | Sentence | denotes | Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 |
T2 | 75-83 | Sentence | denotes | Abstract |
T3 | 84-302 | Sentence | denotes | Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epidemics with high morbidity and mortality. |
T4 | 303-382 | Sentence | denotes | However, there are currently no effective drugs targeting 2019-nCoV/SARS-CoV-2. |
T5 | 383-553 | Sentence | denotes | Drug repurposing, representing as an effective drug discovery strategy from existing drugs, could shorten the time and reduce the cost compared to de novo drug discovery. |